Israel’s NovaSight (see here previously) has received FDA approval for its CureSight digital therapy device for amblyopia (lazy eye). Clearance was given following a multicenter, randomized, controlled trial of 103 participants under 9 years of age. 79% of children improved in the trial.
https://nocamels.com/2023/06/children-watch-tv-to-cure-their-lazy-eye/